Abstract
Introduction
Lupus nephritis (LN) is a severe manifestation of systemic lupus erythematosus (SLE) and is associated with significant morbidity and mortality. However, the course of LN that develops at a younger age is less well understood. Therefore, we evaluated the clinical and laboratory characteristics of adult LN patients and compared them, depending on whether the disease started in childhood (pediatric-onset LN [pLN]) or in adulthood (adult-onset LN [aLN]).
Patients and Methods
We retrospectively analyzed the medical records of all adult LN patients treated at the University Hospital in Kraków, Poland, from 2012 to 2022. All included patients met the European League Against Rheumatism/American College of Rheumatology criteria for SLE from 2019.
Results
Among 343 LN patients, pLN was stated in 46 cases (13.41%). pLN and aLN had a comparably high female-to-male ratio (6.67 vs 4.82, respectively; p = 0.07) and similarly often presented with more advanced kidney involvement in histology. In turn, lupus malar rash and serositis were more frequent in pLN than aLN (p = 0.048 and p = 0.015, respectively). End-stage kidney disease (ESKD) was documented in pLN patients 2.72 times more frequently (p = 0.036); however, the person-year rate did not differ. Interestingly, in pLN we reported a more common presence of anti-cardiolipin antibodies in the IgM class (p = 0.042). The occurrence of other SLE-specific autoantibodies did not differ between both analyzed groups. Regarding immunosuppressive treatment, glucocorticosteroids were the most frequently utilized in both subgroups. Still, pLN cases were more frequently treated with chloroquine or hydroxychloroquine, azathioprine, and immunoglobulins than aLN patients (p < 0.05, for all).
Conclusions
pLN is characterized by more severe SLE clinical manifestations. Therefore, SLE patients who developed LN in childhood likely require more aggressive immunosuppressive treatment.
Keywords
Get full access to this article
View all access options for this article.
References
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
